SEAL™ME: Saccular Endovascular Aneurysm Lattice System Multicenter Enrollment Global Registry
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Osama Zaidat, MD, MS
Mercy Health, OH
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Angiosur
Itagüi, Medellín, Colombia
Boris Pabon, MD, MSRecruiting
- Auckland City Hospital
Auckland, Auckland, New Zealand
James Caldwell, MD, MSRecruiting
- Punjab Institute of Neuroscience (pins)
Lahore, Lahore, Pakistan
Qasim Bashir, MD, MSRecruiting
- Hospital Universitari Vall D'Hebron
Barcelona, Barcelona, Spain
Alejandro Tomasello, MD, MSRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Oct 2023
- Primary completion
- 31 Dec 2026
- Completion
- 15 Jun 2030
- Last update posted
- 4 Apr 2025
- Registered enrollment
- 200
- Registry id
- NCT05880680
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.